Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hamaz Pharma
Multan, Punjab, Pakistanhamazpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Hamaz Pharmaceuticals is a private pharmaceutical manufacturing company based in Multan, Pakistan. Founded in 1999, the company manufactures and distributes a wide range of generic medicines, including antibiotics, cardiovascular drugs, gastroenterology treatments, and anti-inflammatory medications. Its product portfolio features well-known local brands such as Ampimaz (ampicillin), Carves (carvedilol), Hamazol (omeprazole), and Prome (fluoxetine). Hamaz Pharmaceuticals operates a manufacturing facility equipped with production lines for tablets, capsules, liquid syrups, dry suspensions, and ointments, serving the healthcare market across Pakistan.
- Therapeutic areas
- GastroenterologyInfectious DiseasesPsychiatryNeurologyImmunologyCardiovascular
- Modalities
- Small molecule
- Industry
- Pharma
Beyond the preview
Go deeper on Hamaz Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hamaz Pharma.